Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 104

Related Citations for PubMed (Select 18761663)

1.

Alteration of the immunological synapse in lung cancer: a microenvironmental approach.

Derniame S, Vignaud JM, Faure GC, Béné MC.

Clin Exp Immunol. 2008 Oct;154(1):48-55. doi: 10.1111/j.1365-2249.2008.03727.x. Epub 2008 Aug 29.

2.

Successful induction of tumor-specific cytotoxic T lymphocytes from patients with non-small cell lung cancer using CD80-transfected autologous tumor cells.

Takenoyama M, Yoshino I, Eifuku R, So T, Imahayashi S, Sugaya M, Yasuda M, Inoue M, Ichiyoshi Y, Osaki T, Nagashima A, Nomoto K, Yasumoto K.

Jpn J Cancer Res. 2001 Mar;92(3):309-15.

PMID:
11267941
3.

Functional CD8+ T cells infiltrate into nonsmall cell lung carcinoma.

Verdegaal EM, Hoogstraten C, Sandel MH, Kuppen PJ, Brink AA, Claas FH, Gorsira MC, Graadt van Roggen JF, Osanto S.

Cancer Immunol Immunother. 2007 May;56(5):587-600. Epub 2006 Aug 22.

PMID:
16924494
4.

Loss of antigen-presenting molecules (MHC class I and TAP-1) in lung cancer.

Korkolopoulou P, Kaklamanis L, Pezzella F, Harris AL, Gatter KC.

Br J Cancer. 1996 Jan;73(2):148-53.

5.

Comparative T-cell oligoclonality in lung, tumor and lymph nodes in human non-small cell lung cancer.

Derniame S, Vignaud JM, Faure GC, Béné MC, Massin F.

Oncol Rep. 2005 Mar;13(3):509-15.

PMID:
15706426
6.

Expression of major histocompatibility class I and class II antigens and intercellular adhesion molecule-1 on operable non-small cell lung carcinomas: frequency and prognostic significance.

Passlick B, Izbicki JR, Simmel S, Kubuschok B, Karg O, Habekost M, Thetter O, Schweiberer L, Pantel K.

Eur J Cancer. 1994;30A(3):376-81.

PMID:
8204362
7.

Autologous tumor-specific cytotoxic T lymphocytes in a patient with lung adenocarcinoma: implications of the shared antigens expressed in HLA-A24 lung cancer cells.

Takenoyama M, Yoshino I, Fujie H, Hanagiri T, Yoshimatsu T, Imabayashi S, Eifuku R, Nomoto K, Yasumoto K.

Jpn J Cancer Res. 1998 Jan;89(1):60-6.

PMID:
9510477
8.

Spontaneous antibody, and CD4 and CD8 T-cell responses against XAGE-1b (GAGED2a) in non-small cell lung cancer patients.

Ohue Y, Eikawa S, Okazaki N, Mizote Y, Isobe M, Uenaka A, Fukuda M, Old LJ, Oka M, Nakayama E.

Int J Cancer. 2012 Sep 1;131(5):E649-58. doi: 10.1002/ijc.27359. Epub 2012 Jan 3.

PMID:
22109656
10.

Regulatory CD4(+)CD25(+) T cells in tumors from patients with early-stage non-small cell lung cancer and late-stage ovarian cancer.

Woo EY, Chu CS, Goletz TJ, Schlienger K, Yeh H, Coukos G, Rubin SC, Kaiser LR, June CH.

Cancer Res. 2001 Jun 15;61(12):4766-72.

11.

CD8+CD28- cells and CD4+CD25+ regulatory T cells in the peripheral blood of advanced stage lung cancer patients.

Karagöz B, Bilgi O, Gümüs M, Erikçi AA, Sayan O, Türken O, Kandemir EG, Oztürk A, Yaylaci M.

Med Oncol. 2010 Mar;27(1):29-33. doi: 10.1007/s12032-008-9165-9. Epub 2009 Jan 16.

PMID:
19148592
12.

Immunologic parameters as significant prognostic factors in lung cancer.

Nakamura H, Saji H, Ogata A, Hosaka M, Hagiwara M, Kawasaki N, Konaka C, Kato H.

Lung Cancer. 2002 Aug;37(2):161-9.

PMID:
12140139
13.

Analysis of cytotoxic T lymphocytes and Fas/FasL in Japanese patients with non-small cell lung cancer associated with HLA-A2.

Yoshimura C, Nomura S, Kanazawa S, Kuwana M, Muramatsu M, Yamaguchi K, Fukuhara S.

J Cancer Res Clin Oncol. 2002 Nov;128(11):581-8. Epub 2002 Oct 25.

PMID:
12458337
14.

Development of the CD4 and CD8 lineage of T cells: instruction versus selection.

Borgulya P, Kishi H, Müller U, Kirberg J, von Boehmer H.

EMBO J. 1991 Apr;10(4):913-8.

15.

The induction of cytotoxic T lymphocytes against HLA-A locus-matched lung adenocarcinoma in patients with non-small cell lung cancer.

Yoshino I, Takenoyama M, Fujie H, Hanagiri T, Yoshimatsu T, Imabayashi S, Eifuku R, Ogami A, Yano K, Osaki T, Nakanishi R, Ichiyoshi Y, Nomoto K, Yasumoto K.

Jpn J Cancer Res. 1997 Aug;88(8):743-9.

PMID:
9330606
16.

Lysis of a broad range of epithelial tumour cells by human gamma delta T cells: involvement of NKG2D ligands and T-cell receptor- versus NKG2D-dependent recognition.

Wrobel P, Shojaei H, Schittek B, Gieseler F, Wollenberg B, Kalthoff H, Kabelitz D, Wesch D.

Scand J Immunol. 2007 Aug-Sep;66(2-3):320-8.

PMID:
17635809
17.

Tumour-infiltrating lymphocytes in non-small cell lung cancer are activated T lymphocytes.

Kuo SH, Chang DB, Lee YC, Lee YT, Luh KT.

Respirology. 1998 Mar;3(1):55-9.

PMID:
9657662
18.

Restoration of the immunocompetence by IL-2 activation and TCR-CD3 engagement of the in vivo anergized tumor-specific CTL from lung cancer patients.

Chen YM, Yang WK, Whang-Peng J, Tsai WY, Hung YM, Yang DM, Lin WC, Perng RP, Ting CC.

J Immunother. 1997 Sep;20(5):354-64.

PMID:
9336742
19.

Prognostic effect of epithelial and stromal lymphocyte infiltration in non-small cell lung cancer.

Al-Shibli KI, Donnem T, Al-Saad S, Persson M, Bremnes RM, Busund LT.

Clin Cancer Res. 2008 Aug 15;14(16):5220-7. doi: 10.1158/1078-0432.CCR-08-0133.

20.

Selection of peripheral and intestinal T lymphocytes lacking CD3 zeta.

Simpson S, Holländer G, She J, Levelt C, Huang M, Terhorst C.

Int Immunol. 1995 Feb;7(2):287-93.

PMID:
7734423
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk